By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Mapping the Brain’s Cellular Census: A New Atlas Integrates Form and Function of Neuroscience today

A High-Resolution Map of the Brain’s Cellular Diversity of Neuroscience today

Mapping the Brain’s Cellular Universe: A New Atlas Integrates Form, Function, and Genetics of Neuroscience today

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Medicine - The limited prognostic power of exercise ECG in microvascular disease

Medicine

The limited prognostic power of exercise ECG in microvascular disease

Last updated: February 16, 2026 12:53 pm
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

The limited prognostic power of exercise ECG in microvascular disease

A single-centre observational study of 760 chest pain patients with suspected coronary microvascular dysfunction (CMD) found that abnormal ST-segment changes on exercise electrocardiography (ex-ECG) had limited prognostic value. While initial Kaplan-Meier analysis showed a significant separation in major adverse cardiac events (MACE) between patients with abnormal and normal ex-ECG, this association disappeared after adjusting for age, sex, comorbidities, and exercise capacity. The positive predictive value of an abnormal ex-ECG for MACE was only 25%, dropping to 17% when patients with known coronary artery disease were excluded. The study concludes that in patients with suspected CMD, ischaemic ECG changes show poor sensitivity and low predictive value for future cardiac events, though reduced exercise capacity itself remained an independent risk factor.

Why it might matter to you:
This research directly challenges the routine reliance on exercise ECG for risk stratification in a specific, diagnostically challenging patient population. For clinicians, it underscores the importance of a nuanced, multifactorial assessment that prioritizes functional capacity over isolated ECG findings when managing chest pain where microvascular dysfunction is suspected. It provides evidence that could refine clinical decision-making and prevent potentially unnecessary interventions based on a test with limited prognostic utility in this context.


Source →


Stay curious. Stay informed — with
Science Briefing.

Always double check the original article for accuracy.


Feedback

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Spatial skills as a window into Alzheimer’s risk in Down syndrome
Next Article The thermal tightrope of infection: why a parasite thrives in the cold
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

The Hidden Cost of Neglect: Who Funds Pediatric Research in an Age of Austerity?

A New Pathway for Tackling Childhood Obesity in the NHS

A New Front in Cardiovascular Prevention: Evolocumab’s Role in Primary Care for Diabetic Patients

A New Molecular Target for ADHD-Related Cognitive Impairment

The Final Frontier of Surgical Care: Preparing for Robotic Operations in Deep Space

Autoimmunity’s Hidden Trigger: Antibodies Against a Lipid Carrier

Therapy’s Tangible Benefits for Autistic Adults with Depression and Anxiety

Today’s Clinical Medicine Science Briefing | March 16th 2026, 1:00:12 pm

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Gastroenterology
  • Social Sciences
  • Surgery
  • Natural Language Processing
  • Chemistry
  • Cell Biology
  • Engineering
  • Neurology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?